GlobalData on MSN2d
Glooko integrates Abbott’s FreeStyle Libre onto platform
Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.
Abbott Laboratories (ABT): Among the Best Diabetes Stocks to Buy According to Billionaires
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees
Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...
Renal & Urology News3d
Low-Glucose Alerts Beneficial for Insulin-Treated Drivers With Diabetes
Low-glucose alerts improve time below range for drivers with T1D and reduce incidence of low glucose for all insulin-treated drivers ...
Sequel Announces First CGM Integration for its twiist AID System: Abbott's FreeStyle Libre 3 Plus Sensor
We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology 2 as our first CGM partner, marking a significant milestone as we bring our ...
Drug Delivery Business3d
Glooko integrates diabetes management platform with Abbott FreeStyle Libre
Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...
Yahoo Finance3d
Glooko integrates Abbott’s FreeStyle Libre onto platform
Abbott’s continuous glucose monitoring (CGM) device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management. The integration is available for ...